Mediwhale
  • About
    • Founder Story
    • Reti-Intelligence
    • Leadership
    • Journey
  • Products
    • Reti-CVD
    • Reti-CKD
    • Reti-Eye
    • Reti-Age
  • Resources
    • Publications
    • English News
    • Korean News
  • Careers
  • Contact
  • ko_KRKO
Select Page

Validation of deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from US AREDS

Nov 16, 2022 | AHA Scientific Session Abstract

AHA Scientific Session Abstract, November 2022 Background In our previous study, we developed a deep-learning-based novel cardiovascular disease (CVD) risk stratification system based on retinal photographs, Reti-CVD. This study aims to further validate Reti-CVD in...

Validation of a deep-learning-based retinal biomarker (RetiCVD) in the prediction of cardiovascular disease: data from UK Biobank

Nov 16, 2022 | AHA Scientific Session Abstract

AHA Scientific Session Abstract, November 2022 Introduction  Currently in the United Kingdom, cardiovascular disease (CVD) risk assessment is based on the QRISK3 score, with a benchmark of 10% for 10-year CVD risk determining clinical intervention. Yet, effects on...

Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI

Nov 16, 2022 | AHA Scientific Session Abstract

AHA Scientific Session Abstract, November 2022 Introduction  The Korean Ministry of Food and Drug Safety (K-MFDS) has authorized over 110 artificial intelligence (AI)-software as medical devices (AI-SaMDs) for diagnostic purposes. Herein, we clinically validate the...

Let’s build the future of digital healthcare together

Connect with us

ABOUT

Founder Story

Reti-Intelligence

Leadership

Journey

PRODUCTS

Reti-CVD

Reti-CKD

Reti-Eye

Reti-Age

RESOURCES

Publications

News

CAREERS

CONTACT

FOLLOW US

  • Follow
  • Follow

Copyright © 2023 Mediwhale Inc. All rights reserved.      Privacy Policy  |  Terms of Use